A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

Tuszynski, Mark H, Thal, Leon, Pay, Mary, Salmon, David P, U, Hoi Sang, Bakay, Roy, Patel, Piyush, Blesch, Armin +10 more·2005·Nature Medicine
DOI 10.1038/nm1239

Cited by (1,001)

Items 701–800 of 1,001

  1. Homage to Rita Levi-Montalcini. Molecular mechanisms of Alzheimer's disease: NGF modulation of APP processing
    Viviana Triaca · 2013 · Adipobiology
  2. Molecular neurosurgery: vectors and vector delivery strategies
    Edward White · 2012 · British Journal of Neurosurgery
  3. Cholinergic degeneration in early stages of Alzheimer’s disease: Loss of cholinergic phenotype or loss of cells?
    M. Yu. Stepanichev, Olga A. Nedogreeva, Natalia V. Gulyaeva · 2017 · Alzheimer s Dementia & Cognitive Neurology
  4. Treatment of Focal Brain Ischemia with Viral Vector-Mediated Gene Transfer
    Hua Su, Guo‐Yuan Yang · 2010 · Methods in molecular biology
  5. Drug Development for Alzheimer's Disease: Recent Progress
    Wonjin Ji, Ilho Ha · 2010 · Experimental Neurobiology
  6. Choline pivaloyl ester enhances brain expression of both nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis
    Vincenzo Rispoli, Rosario Marra, Nicola Costa, Domenicantonio Rotiroti, Paola Tirassa, Luigi Scipione, Daniela De Vita, Felice Liberatore, Vincenzo Carelli · 2008 · Behavioural Brain Research
  7. Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients
    Tomoyuki Nagata, Nobuto Shibata, Shunichiro Shinagawa, Ritsuko Nakayama, Bolati Kuerban, Tohru Ohnuma, Heii Arai, Kazuhiko Nakayama, Hisashi Yamada · 2013 · Dementia and Geriatric Cognitive Disorders Extra
  8. Natural product promotes repair of injured spinal cord
    Martin Braddock · 2007 · Expert Opinion on Investigational Drugs
  9. Network features and pathway analyses of a signal transduction cascade
    Ryoji Yamashima · 2009 · Frontiers in Neuroinformatics
  10. Neuroprotective Drug Development: The Story of ADNP, NAP (Davunetide), and SKIP
    Illana Gozes · 2017 · Elsevier eBooks
  11. Identification of amino acid residues of nerve growth factor important for neurite outgrowth in human dorsal root ganglion neurons
    Märta Dahlström, Gunnar Nordvall, Erik Sundström, Elisabet Åkesson, Gunilla Tegerstedt, Maria Eriksdotter, Pontus K. A. Larsson Forsell · 2019 · European Journal of Neuroscience
  12. Decoupling the Effects of the Amyloid Precursor Protein From Amyloid-β Plaques on Axonal Transport Dynamics in the Living Brain
    Christopher S. Medina, Taylor W. Uselman, Daniel R. Barto, Frances L. Chaves, Russell E. Jacobs, Elaine L. Bearer · 2019 · Frontiers in Cellular Neuroscience
  13. Modified biopolymer-based systems for drug delivery to the brain
    Abhimanyu Thakur, Rakesh Kumar Sidu, Isha Gaurav, Sweta Kumari, Prosenjit Chakraborty, Sudha Thakur · 2021 · Elsevier eBooks
  14. Neuroprotection in Alzheimer’s Disease
    Kewal K. Jain · 2011 · Humana Press eBooks
  15. In silico biological activity of steroids from the marine sponge Axinella carteri
    V. Anuradha, K. Byju, Emilda Rosmine, Anu Gopinath, S. M. Nair, N. Chandramohanakumar, K. J. Prashob Peter, T. R. Gireesh Kumar, G. Vasundhara · 2012 · Medicinal Chemistry Research
  16. Exploitation of Genetically Modified Neural Stem Cells for Neurological Disease
    Allen Lin Ho, Sassan Keshavarzi, Michael L. Levy · 2010 · Advances in experimental medicine and biology
  17. Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy
    Ahmad Salehi, Alexander M. Kleschevnikov, William Cary Mobley · 2007 · Springer eBooks
  18. Axonal Transport of Neurotrophic Signals: An Achilles' Heel for Neurodegeneration?
    Ahmad Salehi, Chengbiao Wu, Ke Zhan, William Cary Mobley · 2009 · Research and perspectives in Alzheimer's disease
  19. Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders
    Neil Howell, James A. Dykens, Walter H. Moos · 2005 · Drug Development Research
  20. Autologous transplantation in the central nervous system.
    Philippe Taupin · 2006 · PubMed
  21. Neurotrophic Factors and Parkinson’s Disease: The Emergence of a New Player?
    William T. Dauer · 2007 · Science s STKE
  22. Clinical Trials and Drug Development
    Amit Mahipal · 2014 · Cancer Control
  23. Disruption of hippocampal-prefrontal neural dynamics and risky decision-making in a mouse model of Alzheimer’s disease
    Eun Joo Kim, Sanggeon Park, Bryan P. Schuessler, Harry Boo, J. Cho, J. J. Kim · 2024 · bioRxiv
  24. CTAD taskforce: genetic therapies in Alzheimer’s disease
    David Jakabek, Adrian M. Isaacs, Bart De Strooper, Mark H. Tuszynski, Roger M. Lane, Olga Uspenskaya, Eric McDade, Michael S. Rafii, Catherine Jane Mummery · 2025 · The Journal of Prevention of Alzheimer s Disease
  25. The NGF Metabolic Pathway: New Opportunities for Biomarker Research and Drug Target Discovery
    Rowan Pentz, M. Florencia Iulita · 2021 · Advances in experimental medicine and biology
  26. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
    Devank Shekho, Ritika Mishra, Raj Kamal, Rohit Bhatia, Ankit Awasthi · 2024 · AAPS PharmSciTech
  27. Dropping the BACE: Beta Secretase (BACE1) as an Alzheimer’s Disease Intervention Target
    Justin L. Read, Cenk Suphioglu · 2013 · InTech eBooks
  28. Intracerebroventricular Administration of Nerve Growth Factor Induces Gliogenesis in Sensory Ganglia, Dorsal Root, and within the Dorsal Root Entry Zone
    Johannes C. M. Schlachetzki, Donald P. Pizzo, Debbi Ann Morrissette, Jürgen Winkler · 2014 · BioMed Research International
  29. Cognitive Enhancement and the Principle of Need
    Barbro Elisabeth Esmeralda Fröding, Niklas Juth · 2015 · Neuroethics
  30. NGF and therapeutic prospective: what have we learned from the NGF transgenic models?
    Luigi Aloe, Maria Luisa Rocco · 2015 · Annali dell Istituto Superiore di Sanità
  31. Neurotrophin gene therapy for Alzheimer‘s disease
    Armin Blesch · 2006 · Future Neurology
  32. Targeted Delivery of Nucleic Acid Therapeutics via Nonviral Vectors
    Mamta Kapoor, Diane J. Burgess · 2014 · Advances in delivery science and technology
  33. FDG PET in the Evaluation of Mild Cognitive Impairment and Early Dementia
    Lisa Mosconi, Daniel H.S. Silverman · 2009 · Springer eBooks
  34. Links Between Amyloid and Tau Biology in Alzheimer’s Disease and Their Cholinergic Aspects
    George J. Siegel, Neelima B. Chauhan, Alexander G. Karczma · 2007 · Springer eBooks
  35. 1H-MRS Assessment of the Therapeutic Effect of Bilateral Intraventricular BDNF Infusion into APP/PS1 Double Transgenic Mice
    Wei Zhang, Peijun Wang, Minghua Li, Guoliang Wang, Ping Li, Xiaolong Gao · 2013 · Journal of Molecular Neuroscience
  36. Viral approaches to study the mammalian brain: Lineage tracing, circuit dissection and therapeutic applications
    Wei Cong, Yun Shi, Yanqing Qi, Jinyun Wu, Ling Gong, Miao He · 2020 · Journal of Neuroscience Methods
  37. Intravenous and Non-invasive Drug Delivery to the Mouse Basal Forebrain Using MRI-guided Focused Ultrasound
    Kristiana Xhima, Dallan McMahon, Emmanuel E. Ntiri, Maged Goubran, Kullervo Hynynen, Isabelle Aubert · 2021 · BIO-PROTOCOL
  38. Central Nervous System
    Anup Tuladhar, Nikolaos Mitrousis, Tobias Führmann, Molly Sandra Shoichet · 2014 · Elsevier eBooks
  39. Basal Forebrain and Memory
    Andrea A. Chiba, Laleh K. Quinn · 2008 · Elsevier eBooks
  40. Pharmacological treatment for Alzheimer’s disease
    Kongkiat Kulkantrakorn · 2014 · Asian Medical Journal and Alternative Medicine
  41. Neurogenesis-enhancing effect of sodium ferulate and its role in repair following stress-induced neuronal damage
    Lijian Yu, Yongping Zhang, Mingneng Liao, Yanping Wang, Rundi Ma, Xiaoyu Zhang, Tingxi Yu · 2011 · World Journal of Neuroscience
  42. Selective differentiation of central nervous system–derived stem cells in response to cues from specific regions of the developing brain
    Bonnie Vorasubin, John W. Weedin, Farid Saljooque, Nathan Wilkes, Hoi Sang U · 2007 · Journal of neurosurgery
  43. Non-cholinergic drug development for Alzheimer's disease
    Roy Yaari, Shubha Kumar, Pierre N. Tariot · 2008 · Expert Opinion on Drug Discovery
  44. Humans as superorganisms: how microbes, viruses, imprinted genes, and other selfish entities shape our behavior
    Peter Krämer, Paola Bressan · 2021
  45. Targeting Amyloid-β Proteins as Potential Alzheimer’s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health
    Asaad Abdulrahman Abduljawad, Khadijah B. Alkinani, Aysha Zaakan, Abeer S. AlGhamdi, Alashary Adam Eisa Hamdoon, Batool H. Alshanbari, Ahmed Abdullah Alshehri, Badria Bakheet Alluhaybi, Shahad Othman Ibrahim Alqashi, Ryan Abdulrahman Abduljawad · 2025 · Pharmaceuticals
  46. Co‐pathologies and biological processes beyond amyloid‐beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies
    Daniel Ferreira, Tomasz Chmiela, Maria Eriksdotter, Clifford R. Jack, Grégoria Kalpouzos, Anna Marseglia, Patrizia Mecocci, Agneta K. Nordberg, Dorota Religa, Eric Westman · 2026 · Journal of Internal Medicine
  47. A Potential Strategy for Treatment of Neurodegenerative Disorders by Regulation of Adult Hippocampal Neurogenesis in Human Brain
    Wei-Song Xie, Kiran Shehzadi, Hong-Le Ma, Jian‐Hua Liang · 2022 · Current Medicinal Chemistry
  48. Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases
    Eric T. Ebert, Kelly Schwinghamer, Teruna J. Siahaan · 2024 · Life
  49. Present insights into the progress in gene therapy delivery systems for central nervous system diseases
    Zefeng Yang, Xinchi Jiang, Jianqing Gao · 2024 · International Journal of Pharmaceutics
  50. Therapeutic Applications of Dental Mesenchymal Stem Cells in Alzheimer’s Disease—A Scoping Review
    Rupali Agnihotri, Sumit Gaur · 2025 · Dentistry Journal
  51. Intravenous Transplantation of Human Umbilical Cord Blood Mononuclear Cells Overexpressing Nerve Growth Factor Improves Spatial Memory in APP/PS1 Transgenic Mice with a Model of Alzheimer’s Disease
    Marat A. Mukhamedyarov, Alina V. Leushina, A. E. Tikhonova, Elena O. Petukhova, Ekaterina Evgenevna Garanina, R. Ben Taleb, М. С. Калигин, Yana Olegovna Mukhamedshina, Albert Anatolyevich Rizvanov, Andrey Lvovich Zefirov et al. · 2017 · BioNanoScience
  52. Nanomaterials for the treatment of spinal cord injury
    Jing Yang, Hairong Jin, Chengxuan Tang, Liangle Liu · 2024 · Applied Materials Today
  53. Traitement symptomatique de la maladie d’Alzheimer et perspectives thérapeutiques
    Françoise Forette, Jean‐Jacques Hauw · 2010 · Therapies
  54. Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma
    Barbara Lortal, Fabian Gross, Jean‐Marie Péron, Marie Pénary, Danièle Berg, Isabelle Hennebelle, Gilles Favre, Bettina C. Couderc · 2008 · Cancer Gene Therapy
  55. [Neurotrophic control in the development and function of two endocrine organs: the ovary and the pancreas].
    Siraam Cabrera-Vásquez · 2007 · PubMed
  56. Terapias antienvejecimiento aplicadas a la enfermedad de Alzheimer
    Gara S. Alonso Abreu, José Miguel Brito Armas, Rafael Castro Fuentes · 2017 · Revista Española de Geriatría y Gerontología
  57. Dexmedetomidine Improves Locomotor Function and Alleviates Thermal Hyperalgesia Following Sciatic Nerve Crush Injury in Rats
    Myung-Soo Jang, Jin‐Hee Han, Dong-Ok Kim, Gil Woo, Jae-Ik Kwon, Jun-Young Chung, Bong-Jae Lee, Jae-Woo Yi · 2020 · International Neurourology Journal
  58. Current clinical approaches in neurodegenerative diseases
    Miguel Fernandes Gago, Álvaro Sosa Machado, Sofia Rocha · 2020 · Elsevier eBooks
  59. Neuroprotection in Alzheimer Disease
    Kewal K. Jain · 2019 · Springer protocols handbooks/Springer protocols
  60. Stereotaxic-assisted gene therapy in Alzheimer’s and Parkinson’s diseases: therapeutic potentials and clinical frontiers
    Samar O. El-Ganainy, Tony Cijsouw, Mennatallah A. Ali, Susanne Schoch, Amira Sayed Hanafy · 2022 · Expert Review of Neurotherapeutics
  61. Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications
    Liang‐Fong Wong, Lucy Goodhead, Christine M. A. Prat, Kyriacos A. Mitrophanous, Susan M. Kingsman, Nicholas D. Mazarakis · 2005 · Human Gene Therapy
  62. Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels
    Dimitar G. Tonev, Albena Momchilova · 2023 · Current Issues in Molecular Biology
  63. Aging, Dementia, and Alzheimer Disease
    Harald W. Sontheimer · 2015 · Elsevier eBooks
  64. Alzheimer and It’s Possible Therapy: A Review
    2020 · Journal of Experimental Neurology
  65. Emerging Therapeutic Strategies in Alzheimer's Disease
    Tomohiro Chiba · 2013 · InTech eBooks
  66. Stem Cell in Neurological Disorders
    Nirmeen Adel Kishk, Noha Abokrysh · 2011 · InTech eBooks
  67. Application of Neurotrophic Factors as a Therapeutic Approach for Neurodegenerative Diseases
    S. Kim, S.Y. Lee, Un Ju Jung, Sang Ryong Kim · 2025 · Experimental Neurobiology
  68. Cognition and modulation of the cholinergic system
    Peter Jeffrey Snyder, Paul T. Maruff · 2025 · Handbook of clinical neurology
  69. Biologics for the management of dementia
    Akash Chaurasiya, Sumeet Katke, Kanan Panchal, Jayabalan Nirmal · 2022 · Elsevier eBooks
  70. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery
    Luc Zimmer · 2023 · Expert Opinion on Drug Discovery
  71. Intranasal delivery of human Wharton’s jelly-derived mesenchymal stem cells alleviates Aβ-induced Alzheimer’s symptoms in rat models by regulating neurotrophic and apoptotic factors
    Ebrahim Eslami, Farshid Ghiyamihoor, Marjan Sadr, Marziyeh Ajdary, Sahar Hakimpour, Rana Mehdizadeh, Ronak Shabani, Mehdi Mehdizadeh · 2024 · Neuroscience and Behavioral Physiology
  72. Clinical neurorestorative progress in Alzheimer’s disease
    Liyan Qiao, Hongyun Huang, Dafin Fior Muresanu · 2014 · Journal of Neurorestoratology
  73. Can painting human cells with exogenous maltoporin enable efficient therapeutic gene transfer by bacteriophage lambda vectors?
    Diógenes Infante · 2009 · Electronic Journal of Biotechnology
  74. Stem Cell Therapies for Neurodegenerative Disorders: An Ethical Analysis
    Sorin Hostiuc, Ionuţ Negoi, Mugurel Constantin Rusu, Mihaela Hostiuc · 2018 · Elsevier eBooks
  75. Effective Transduction of Brain Neurons with Lentiviral Vectors Purified via Ion-Exchange Chromatography
    Elizaveta V. Shaburova, Dmitriy A. Lanshakov · 2021 · Applied Biochemistry and Microbiology
  76. Advances in stromal cell therapy for management of Alzheimer’s disease
    Rashi Srivastava, Aidong Li, Tirtharaj Datta, Niraj Kumar Jha, Salehikram Talukder, Saurabh Kumar Jha, Zhe‐Sheng Chen · 2022 · Frontiers in Pharmacology
  77. The relationships between neuroglial and neuronal changes in Alzheimer’s disease, and the related controversies II: gliotherapies and multimodal therapy
    Adolfo Toledano‐Díaz, M Isabel Álvarez, A. Tolédano · 2022 · Journal of Central Nervous System Disease
  78. A triple chain polycationic peptide-mimicking amphiphile – efficient DNA-transfer without co-lipids
    Shashank Reddy Pinnapireddy, Julia Giselbrecht, Boris Strehlow, Christopher Janich, Catharina Husteden, Annette Meister, Harald Loppnow, Daniel Sedding, Frank Erdmann, Gerd Hause et al. · 2019 · Biomaterials Science
  79. Gene Therapy
    Hao Wu, Amit Chaudhary, Ram I. Mahato · 2019 · Springer eBooks
  80. Stem-cell therapy for neurologic diseases
    Shilpa Sharma, Devendra Kumar Gupta · 2015 · Journal of Neuroanaesthesiology and Critical Care
  81. Perspectivas en la prevención y tratamiento farmacológico de la enfermedad de Alzheimer
    S Archibaldo Donoso, Carolina Delgado D · 2009 · Revista médica de Chile
  82. NGF and BDNF Gene Therapy for Alzheimer’s Disease
    Mark H. Tuszynski, Alan H. Nagahara · 2016 · Springer eBooks
  83. Trafficking of Neurotrophins and Their Receptors and Pathological Significance
    Christopher S. von Bartheld · 2014 · Springer eBooks
  84. Glial Alterations in Aging and Alzheimer’s Disease: A Novel Basis to Understand, Prevent and Treat the Degenerative Process
    Adolfo Toledano‐Díaz, María‐Isabel Álvarez, A. Tolédano · 2020 · OBM Geriatrics
  85. Lipofection with estrone-based luminophores featuring aggregation-induced emission properties
    Steffen Riebe, Alexander Zimmermann, Johannes Koch, Cecilia Vallet, Shirley K. Knauer, Andrea Sowa, Christoph Wölper, Jens Voskuhl · 2020 · RSC Advances
  86. Microfluidic chip for label-free removal of teratoma-forming cells from therapeutic human stem cells
    Kyle Wellmerling, Christian Lehmann, Ankur K. Singh, Brian J. Kirby · 2020 · Journal of Immunology and Regenerative Medicine
  87. Adeno‐associated Viral Vectors in Gene Therapy
    Chen Ling, Li Zhong, Arun Srivastava · 2018 · Wiley eBooks
  88. Commentary: Aβ(1–42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels
    Krista L. Lanctôt, Nathan Herrmann, Lana S. Rothenburg · 2008 · Experimental Neurology
  89. New Paradigm for Brain Protection After Stroke
    Masaki Mogi, Masaru Iwai, Masatsugu Horiuchi · 2006 · Hypertension
  90. Terapia génica. Perspectivas y consideraciones éticas en relación con su aplicación
    Salomé Rocío García Miniet, María Elena González Fraguela · 2008 · DOAJ (DOAJ: Directory of Open Access Journals)
  91. Retracted: 1H-MRS can monitor metabolites changes of lateral intraventricular BDNF infusion into a mouse model of Alzheimer’s disease in vivo [Neuroscience 245 (2013) 40–49]
    W. Zhang, P.J. Wang, M.H. Li, Xiaolong Gao, G.J. Gu, Z.H. Shao · 2013 · Neuroscience · Retracted
  92. Stimulation of Cerebral Angiogenesis by Gene Delivery
    Yaohui Tang, Yaning Li, Xiaojie Lin, Peng Miao, Yongting Wang, Guo-Yuan Yang · 2014 · Methods in molecular biology
  93. Transplants of CNTF-producing Cells for the Treatment of Huntington's Disease
    Carole Escartin, Philippe Hantraye, Nicole Déglon · 2007 · Elsevier eBooks
  94. The Blood-Brain Barrier in vitro Using Primary Culture: Implications for Studies of Therapeutic Gene Expression and Iron Transport
    Annette Burkhart · 2015
  95. Preparation of mNGF-conjugated Iron Oxide Nanoparticles and Repair of Peripheral Nerve Injury in Rats Under Applied External Magnetic Field
    Lijun Li, Haimiti Abuduaini, Dongkui Ni, Yanyun Shi, F. Zhu, Q. Zong · 2020 · Indian Journal of Pharmaceutical Sciences
  96. Progress in the development of new drugs in Alzheimer’s disease
    Antoine Piau, Fati Nourhashémi, Christophe Hein, Céline Caillaud, Bruno J. Vellas · 2010 · The journal of nutrition health & aging
  97. Harnessing the Power of Osmolytes for Industrial and Pharmaceutical Applications
    Shatrunjai Giri, Pratishtha Singh, Madhuja Biswas, Roopal Mishra, Nitesh Kumar Poddar · 2024 · Springer eBooks
  98. Oligodendrocytes, the Forgotten Target of Gene Therapy
    Yasemin Ozgür-Gunes, Catherine Le Stunff, Pierre F Bougneres · 2024 · Cells
  99. Current approaches and future directions of gene therapy in Alzheimer’s disease
    M. Yu. Stepanichev · 2011 · Neurochemical Journal
  100. Gene Therapy in the Nervous System: Failures and Successes
    Jayanth S. Chandran, Joseph M. Scarrott, Pamela J. Shaw, Mimoun Azzouz · 2017 · Advances in experimental medicine and biology